Products
Products
Explore our advanced sequencing products for turning complex molecular signals into high-confidence readouts across clinical testing, RNA quality control, and translational methylation programs.
NeuroLens®
Neuron Cell-Death Test
RNA Clarity™
RNA Vaccine QC
MethylMap™
Native-Read Methylation Sequencing
Older woman discussing a clinical diagnosis with a female doctor who is reviewing a tablet in a medical office.
Services
Services
End-to-end sequencing services supporting genomic, epigenomic, and transcriptomic analysis, from experimental design and assay development to bioinformatics, interpretation, and data delivery.
Applications
Applications
Explore how our products and services help solve difficult biological and genomic problems, from liquid biopsy signals to complex regions and emerging biomarker development.
Hard-to-Sequence Genes & Complex Regions
Liquid Biopsy cfDNA Analysis
Targeted Panel Development
Close-up of overlapping teal and green curved panels with light reflections and a smooth gradient.
Company
Company
Building the future of precision diagnostics through sequencing innovation, scientific rigor, and collaborative partnerships.
About Us
Team
Building with a black facade featuring white 3D letters spelling 'RENEW' and a geometric logo.
Resources
Contact
  • Applications
  • Applications
    Telomeres, the protective caps at the end of our chromosomes, sit at the intersection of aging, cancer, and neurodegeneration research.
    Telomeres, the protective caps at the end of our chromosomes, sit at the intersection of aging.
    Research & Translation
    Biopharma Research
    Clinical Development
    Abstract digital pattern of glowing rectangular bars in green and blue on a dark background.
  • Company
  • Company
    Building the future of precision diagnostics through sequencing innovation, scientific rigor, and collaborative partnerships.
    About Us
    Team
    Building with a black facade featuring white 3D letters spelling 'RENEW' and a geometric logo.
Renew Service

Development  & Validation

  • Renew helps teams advance complex sequencing workflows from early development through clinical, regulatory, and operational readiness. By integrating wet-lab development, bioinformatics, and regulatory-aligned quality systems, we generate fit-for-purpose evidence from the start.
Start A Project

Specialized Support For Complex Sequencing Workflows

Long-read sequencing reveals biological signals that conventional methods often miss, but translating those signals into clinical assays requires more than sequencing alone. Renew combines clinical Nanopore expertise, internal R&D, and sample strategy to help partners move complex workflows from concept to clinical deployment.
DNA icons
Clinical Nanopore Translation
Advance ONT-based workflows through long-read expertise, native-read applications, and clinical translation.
interesting process icon
R&D-Driven Development
Develop, optimize, and characterize complex assays before validation or regulated deployment.
circular graph shape icon
Sample Strategy for Validation
Plan cohort access, sample feasibility,
and evidence generation for complex validation studies.

Fit-for-Purpose
Evidence Generation

Every development program has a different objective. Renew tailors study design, analytical rigor, documentation, and validation strategy to each workflow's intended use, regulatory pathway, and development milestone.

Whether supporting RUO verification, GCP-compliant studies, CAP/CLIA implementation, or FDA-facing analytical validation, we generate the evidence required for the next decision.
Evidence built for every stage of development
Fit-for-purpose RUO verification
GCP-aligned clinical and translational studies
CAP/CLIA validation planning and execution
FDA-facing analytical evidence generation

Plan. Develop. Verify. Validate

A fit-for-purpose path to clinical and regulatory readiness
1. Plan
Define intended use, development strategy, sample requirements, 
and evidence needs.
2. Develop
Build and refine wet-lab workflows, bioinformatics, QC frameworks, and analytical outputs.
3. Verify
Establish analytical performance across research, translational, or clinical development studies.
4. Validate
Generate analytical and clinical evidence aligned to implementation and regulatory objectives.
5. Submit
Support regulatory strategy, submission documentation, and agency interactions.

Built for Clinical Deployment

Clinical deployment is built into our development model, allowing programs to transition seamlessly from validation into routine clinical execution.

Regulatory-aligned laboratory operations, specialty bioinformatics, LIMS, API-enabled data delivery, validation documentation, QC systems, and change control provide the operational foundation for scalable testing and long-term program growth.

Infrastructure for clinical translation
15,000 square feet of dedicated sequencing and development space
CAP-accredited, CLIA-certified laboratory operations
HIPAA-aligned processes for clinical and partner programs
Custom LIMS-enabled sample and workflow tracking
Specialty bioinformatics for complex sequencing workflows
Partner Highlight

Path Fertility’s NOA GUIDE™

Path Fertility partnered with Renew to develop and validate NOA Guide, an epigenetic test for men with non-obstructive azoospermia, a condition characterized by impaired sperm production despite no physical obstruction.

Renew provided assay development, validation, and clinical laboratory implementation, translating novel epigenetic biology into an operational diagnostic with real-world clinical utility.

Develop and Validate with Confidence
Advance from development to deployment with a fit-for-purpose validation strategy aligned to your workflow, intended use, and next milestone.
Start A Project Today
Discover More
Join For Updates
Success! Thank you for joining our newsletter.
Oops! Something went wrong while submitting the form.
© 2026 Renew Biotechnologies | All Rights Reserved
CAP 7654476 | CLIA 46D2309073